ArticleMolecules (Basel, Switzerland)2022

Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo.

Yurou Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.